YorkBridge Wealth Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
YorkBridge Wealth Partners's RMD Position: Q4 2022 in Review
YorkBridge Wealth Partners reduced its ResMed (RMD) stake by 4.5% in Q4 2022, selling an estimated $14.3K and leaving 1,389 shares worth $289K. The position accounts for 0.07% of the portfolio, ranked #201.
YorkBridge Wealth Partners first reported a position in RMD in Q4 2016 and has held it in 20 quarters since. The position peaked at $425K in Q4 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.
- YorkBridge Wealth Partners held 1,389 shares of ResMed worth $289K as of Q4 2022.
- YorkBridge Wealth Partners sold 65 ResMed shares in Q4 2022, an estimated $14.3K.
- ResMed made up 0.07% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #201 holding.
- YorkBridge Wealth Partners first reported a position in ResMed in Q4 2016 and has held it in 20 quarters since.
- YorkBridge Wealth Partners's ResMed position peaked at $425K in Q4 2021.
- 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.
Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.